Menu

Kees2

Logo Alt Text
  • Home
  • VarmX
  • Lead product
  • Pipeline
  • News
  • Contact
  • Home
  • VarmX
  • Lead product
  • Pipeline
  • News
  • Contact

VMX-C001 intended to stop bleeding

Aimed at restoring blood clotting in the presence of direct factor Xa anticoagulants

Read more

Uitgelichte items

Latest news

VarmX raises €30 million Series B2 financing for IND approval and preparations for pivotal trial

25 May 2023

- Sound Bioventures and EIC Fund join existing investors EQT Life Sciences (formerly LSP), Inkef, Lundbeckfonden BioCapital, Ysios Capital, BioGeneration Ventures, InnovationQuarter and Libertatis Ergo Holding
- Proceeds to be used to obtain IND approval for VMX-C001 and complete preparations for pivotal trial, including large scale manufacturing

Meet us

24 June 2023

International Society on Thrombosis and Haemostasis, Montreal, Canada

This website uses functional and analytical cookies. Accept Deny
  • info@varmx.com
  • Disclaimer
  • Cookies